Skip to main content
. 2021 Oct 2;19:412. doi: 10.1186/s12967-021-03075-y

Fig. 3.

Fig. 3

Characterization of hsa_circ_0005092 and hsa_circ_0002647. a The RT-PCR product of the hsa_circ_0005092 is verified by sanger sequencing. b qRT–PCR analysis for the expression of hsa_circ_0005092 and its host gene after actinomycin D treatment for 0 h, 3 h, 6 h, 9 h, and 12 h in SNU-1 cells. c RNase R resistance assay for has_circ_0005092 in SNU-1 and MKN-45 cells. d The RT-PCR product of the hsa_circ_0002647 is verified by sanger sequencing. e qRT–PCR analysis for the expression of hsa_circ_0002647 and its host gene after actinomycin D treatment. f RNase R resistance assay for has_circ_0002647 in SNU-1 and MKN-45 cells. IPO7, importin 7; EHMT1, euchromatic histone lysine methyltransferase 1